Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?

Sodium-glucose-transporter 2 inhibitors (SGLT2i) are a new class of anti-diabetic drugs that in large trials such as CREDENCE have shown also a reduction of glomerular hyperfiltration and albuminuria in type 2 diabetic patients. Hence, the interest toward SGLT2i is focused toward this potential neph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Med (Lausanne)
Hauptverfasser: Cupisti, Adamasco, Giannese, Domenico, Moriconi, Diego, D'Alessandro, Claudia, Torreggiani, Massimo, Piccoli, Giorgina B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020
Schlagworte:
Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793896/
https://ncbi.nlm.nih.gov/pubmed/33425967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.622593
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge